Skip to main content

Table 4 Mean hair loss at the end of CT (last rated CT-cycle) evaluated by patients (PE) and rated by expert (ER) Threshold for successful scalp cooling is 50% (visible) hair loss, i.e. the limit between grades 2 and 3 (n (%))

From: Successful reduction of alopecia induced by anthracycline and taxane containing adjuvant chemotherapy in breast cancer – clinical evaluation of sensor-controlled scalp cooling

Grade (hair loss) Success No success
  0 1 2 3 4
(Neo-)adjuvant CT   
Success rate 31 (52.6) 28 (47.5)
Σ all CT PE
Σ all CT ER 31 (53.5) 271 (46.6)
PE 1 (1.7) 7 (11.9) 23 (39.0) 19 (32.2) 9 (15.3)
ER1 3 (5.2) 12 (20.7) 16 (27.6) 19 (32.8) 8 (13.8)
Success rate 2 (66.6) 1 (33.3)
Σ all EC PE
Σ all EC ER 1 (33.3) 2 (66.6)
EC PE - 1 (33.3) 1 (33.3) - 1 (33.3)
EC ER - 1 (33.3) - 1 (33.3) 1 (33.3)
Success rate 15 (46.8) 17 (53.1)
Σ all EC/Doc PE
Σ all EC/Doc ER 17 (54.9) 14 (45.2)
EC/Doc PE 1 (3.1) 5 (15.6) 9 (28.1) 13 (40.6) 4 (12.5)
EC/Doc ER1 2 (6.5) 6 (19.4) 9 (29.0) 11 (35.5) 3 (9.7)
Success rate 9 (60.0) 6 (40.0)
Σ all FEC PE
Σ all FEC ER 9 (60.0) 6 (40.0)
FEC PE - 1 (6.7) 8 (53.3) 3 (20.0) 3 (20.0)
FEC ER 1 (6.7) 5 (33.3) 3 (20.0) 5 (33.3) 1 (6.7)
Success rate 4 (57.1) 3 (42.9)
Σ all FEC/Doc PE
Σ all FEC/Doc ER 2 (28.6) 5 (71.5)
FEC/Doc PE - - 4 (57.1) 2 (28.6) 1 (14.3)
FEC/Doc ER - - 2 (28.6) 2 (28.6) 3 (42.9)
Palliative CT   
Success rate 6 (100) -
Σ all PE
Σ all ER 5 (83.4) 1 (16.7)
PE 1 (16.7) 4 (66.7) 1 (16.7) - -
ER 3 (50) 1 (16.7) 1 (16.7) 1 (16.7) -
  1. 1The African patient was not rated.